News & Updates from Repair Biotechnologies

Featured Article

Repair Biotechnologies Announces Appointment of Noted Cardiologists to Scientific Advisory Board

Featured Article

Repair Biotechnologies Demonstrates Rapid Reversal of Atherosclerosis in Mouse Models

Featured Article

Repair Biotechnologies Announces 48% Reversal of Atherosclerotic Plaque Lipids in a Preclinical Mouse Study

Top Reads

Repair Biotechnologies Announces Appointment of Noted Cardiologists to Scientific Advisory Board

Repair Biotechnologies Demonstrates Rapid Reversal of Atherosclerosis in Mouse Models

Repair Biotechnologies Announces 48% Reversal of Atherosclerotic Plaque Lipids in a Preclinical Mouse Study

Previous

Next

Latest News

Repair Biotechnologies Announces Appointment of Noted Cardiologists to Scientific Advisory Board

Repair Biotechnologies Demonstrates Rapid Reversal of Atherosclerosis in Mouse Models

Repair Biotechnologies Announces 48% Reversal of Atherosclerotic Plaque Lipids in a Preclinical Mouse Study

Reason to present at the 6th Aging Research for Drug Discovery Forum in Basel

Repair Biotechnologies Raises $2.15M Seed Round to Develop Drugs for Age-Related Diseases

Repair Biotechnologies Closes Pre-Seed Round, Joins Grapeseed.bio Incubator

About

Navigate

Contact

Repair Biotechnologies, Inc.
841 East Fayette St
Syracuse, NY 13210